This inhibition of peak Na+ current is clinically important because reductions of peak Na+ current amplitude (arising primarily from mutations in Nav1.5) account for a large fraction of arrhythmias seen in Brugada syndrome patients, regardless of whether amplitude reduction arises from disrupted channel trafficking or function (25, 49). Here, SCN5A is linked to Arrhythmia.